Medical tube and preparation method thereof

By using a combination of polypropylene inner layer and ethylene vinyl acetate copolymer intermediate layer and thermoplastic polyurethane outer layer in medical tubes, the interaction and absorption problems of traditional Chinese medicine tubes when contacting aqueous fluids in the prior art are solved, ensuring the formulation integrity and structural stability.

CN118891069APending Publication Date: 2024-11-01TEKNI PLEX INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380019530.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-06-17
Filing Date
2023-06-16
Publication Date
2024-11-01

AI Technical Summary

Technical Problem

Existing medical polymer tubes may experience undesirable interactions and absorption when in contact with aqueous fluids, especially insulin and other pharmaceutical compositions, resulting in impairment of the integrity of the formulation and at low to moderate pressures and Under mechanical operating conditions, adhesion cannot be maintained between the inner and outer layers.

Method used

Polypropylene is used as the inner layer material, and through the coextrusion process, it is used to combine the inner and outer layers with ethylene vinyl acetate copolymer, ethylene acrylate copolymer and other materials as the intermediate transition layer to prevent delamination, and thermoplastic polyurethane is selected Or cycloolefin copolymers act as outer layer to ensure structural integrity under moderate stress and strain conditions.

Benefits of technology

It effectively prevents the absorption and layering of drug ingredients, protects the integrity of the preparation, and maintains the transparency and adhesion of the tube after being immersed in high temperature and water. It is suitable for transporting aqueous fluids in the body.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0004970466860000011
    Figure HDA0004970466860000011
  • Figure HDA0004970466860000012
    Figure HDA0004970466860000012
  • Figure HDA0004970466860000021
    Figure HDA0004970466860000021
Patent Text Reader

Abstract

In one embodiment, a visually clear or transparent manually flexible medical tube (10) suitable for in vivo delivery of an aqueous fluid to a subject comprises an inner layer (3) comprising polypropylene, an intermediate layer (2), and an outer layer (1) comprising a thermoplastic polyurethane or cycloolefin copolymer, the middle layer (2) is selected from one or more of an ethylene vinyl acetate copolymer, an ethylene acrylate copolymer, an ethylene-acrylic acid maleic anhydride terpolymer, an ethylene-acrylate glycidyl methacrylate terpolymer and maleic anhydride grafted polypropylene.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to polymeric tubes for delivering medical fluids to a patient and methods of making such tubes, generally by a coextrusion process, wherein the tubes have multiple layers of the same or different polymeric materials, each layer being sequentially adhered to one another. Background Art

[0002] Tubing composed of polymeric materials is used in many industrial and commercial applications, including medical applications. A variety of FDA-compliant plastics are used, depending on the desired properties and intended application. When tubing is used to deliver fluids for in vivo treatment of human patients, the choice of polymeric material can be an influencing factor.

[0003] As disclosed in U.S. Pat. No. 10,646,704, polyethylene-based polymers have been used as the innermost layer of a three-layer tube in contact with medical fluids, wherein the innermost polyethylene layer is bonded to the outermost layer of polyurethane by an intermediate or intermediate transition layer of adhesive. Although this tube structure has certain advantages, the polyethylene tube layer in contact with typical medical treatment aqueous fluids may have negative interactions with certain commonly used medical fluids (e.g., aqueous compositions of insulin and other drugs).

[0004] Polyvinyl chloride (PVC) is one of the most widely used plastics. Although the structure is stable and easy to be formed into the desired shape, the manufacture of PVC usually uses plasticizers, which can migrate from the PVC matrix to the body fluids and have other characteristics that are not suitable for medical treatment applications. Similarly, due to the inherent properties of plasticized PVC tubes, drugs used in medical treatment and other components of aqueous liquids may be absorbed by the side walls of PVC tubes. Polyurethane may become a substitute for PVC. However, the double-layer tube composed of polyurethane and polyethylene faces the problem of being unable to keep the two layers adhered to each other under low to medium pressure, strain or mechanical operation conditions. U.S. Patent No. 4,627,844 of Schmitt ("Schmitt") discloses a three-layer tube, which is included in the commercial product sold by the Natvar department of Tekni-Plex Inc. under the trademark "SUREPATH 151", and the disclosure of the patent is incorporated herein by reference. As disclosed in Schmitt, an outer layer of PVC and an inner fluid contacting layer of low density polyethylene (LDPE) are coextruded with an ethylene vinyl acetate copolymer (EVA) middle tie layer. However, while Schmitt's inner polyethylene layer may be inert or non-interfering with the components of certain medical fluids, polyethylene may negatively interact with the components of other medical fluids, such as many common fluid compositions containing insulin. Summary of the invention

[0005] As mentioned above, tubes with a polyethylene inner layer may interact negatively with drug ingredients over an extended period of time.

[0006] According to the present invention, the selection of polypropylene as the inner layer polymer material can prevent the undesired loss of components / drug ingredients due to absorption, protecting the integrity of the formulation during normal use of the tube to deliver aqueous fluids (e.g., delivery of drug suspensions, chemotherapeutic drugs and insulin to human subjects).

[0007] A disadvantage of double-layered tubes consisting of an inner polypropylene layer and an outer polyurethane layer is that the two layers do not remain adhered to each other.

[0008] The present invention relates to an inner layer, an outer layer, and an intermediate transition layer, wherein the intermediate transition layer bonds the inner layer and the outer layer together and prevents the multilayer structure from delamination under moderate stress, strain or mechanical operation.

[0009] Selection of an appropriate interlayer polymer material can prevent delamination of the multilayer structure, thereby protecting the integrity of the tube, the tube and fitting bond, and the delivered formulation.

[0010] The polymer material of the middle layer is selected from one or more of ethylene vinyl acetate copolymer, ethylene acrylate copolymer, ethylene-acrylate maleic anhydride terpolymer, ethylene-acrylate glycidyl methacrylate terpolymer, and maleic anhydride grafted polypropylene.

[0011] Thermoplastic polyurethane as an outer layer is beneficial in medical tubing where the presence of plasticizers in PVC makes it less than ideal as a medical tubing. TPU can bond securely to fittings during post-manufacturing processing of the tube and medical device assembly. Alternatively, the TPU outer layer can be replaced with a cyclic olefin copolymer to provide the desired performance characteristics at a lower cost.

[0012] In one embodiment of the present invention, a tube (10) suitable for in vivo delivery of an aqueous fluid to a subject comprises an inner layer (3), an intermediate layer (2), and an outer layer (1),

[0013] The tube is prepared by a co-extrusion process, the inner layer (3), the middle layer (2) and the outer layer (1) are all coaxial, the inner layer (3) and the outer layer (1) are bonded to the middle layer (2), and thus bonded to each other.

[0014] wherein the inner layer (3) comprises polypropylene,

[0015] The outer layer (1) comprises thermoplastic polyurethane, and

[0016] The middle layer (2) is selected from one or more of ethylene vinyl acetate copolymer, ethylene acrylate copolymer, ethylene-acrylate maleic anhydride terpolymer, ethylene-acrylate glycidyl methacrylate terpolymer and maleic anhydride grafted polypropylene.

[0017] In one embodiment of the present invention, the intermediate layer (2) comprises ethylene ethyl acrylate copolymer or ethylene methyl acrylate copolymer or anhydride grafted ethylene methyl acrylate copolymer, copolymers of two or more of said acrylates or mixtures of two or more of the above.

[0018] In one embodiment of the present invention, the intermediate layer (2) comprises ethylene vinyl acetate.

[0019] In one embodiment of the present invention, the inner layer (3) comprises more than 90 wt% of a polypropylene homopolymer or a polypropylene copolymer, the outer layer (1) comprises more than 90 wt% of an aromatic or aliphatic polyether-based polyurethane, and the middle layer (2) comprises more than 90 wt% of one or more of the following: ethylene vinyl acetate copolymer, ethylene acrylate copolymer, ethylene-acrylate maleic anhydride terpolymer, ethylene-acrylate glycidyl methacrylate terpolymer and maleic anhydride grafted polypropylene.

[0020] In one embodiment of the present invention, the intermediate layer (2) comprises ethylene ethyl acrylate copolymer having an ethyl acrylate content of at least 19.5% by weight.

[0021] In one embodiment of the present invention, the intermediate layer (2) comprises more than 90% by weight of ethylene methyl acrylate copolymer.

[0022] In one embodiment of the present invention, the intermediate layer (2) comprises ethylene vinyl acetate having a vinyl acetate content of at least 19.5% by weight.

[0023] In one embodiment of the present invention, the inner layer (3) comprises more than 90 wt% of a polypropylene homopolymer or a polypropylene copolymer or a mixture thereof and the outer layer (1) comprises more than 90 wt% of a polytetramethylene glycol based polyurethane.

[0024] In one embodiment of the invention, the thickness of the outer polyurethane layer is 0.0254 mm to 0.635 mm (0.001 inch to 0.025 inch), the thickness of the inner polypropylene layer is 0.0254 mm to 0.635 mm (0.001 inch to 0.025 inch), and the thickness of the middle layer is 0.0254 mm to 0.635 mm (0.001 inch to 0.025 inch).

[0025] In one embodiment of the present invention, the inner layer (3) and the outer layer (1) do not visually delaminate from the middle layer (2) at a stress of at most 20 MPa and a strain of at most 400%.

[0026] In one embodiment of the present invention, the tube (10) is visually free of delamination when immersed in water at 60°C for 72 hours.

[0027] In one embodiment of the present invention, the tube (10) has a central axial fluid flow channel through which an aqueous fluid flows, the inner layer (3) has a radial inner wall surface in contact with the aqueous fluid, and under a stress of up to 20 MPa and a strain of up to 400%, the outer layer (1) and the inner layer (3) will not delaminate from the middle layer (2), and wherein the tube (10) is visually free of delamination after being immersed in water at 60°C for 72 hours.

[0028] In one embodiment of the present invention, the inner layer (3) and the outer layer (1) do not visually delaminate from the middle layer (2) under a stress of up to 20 MPa and a strain of up to 400%, and wherein the tube (10) does not visually delaminate after being immersed in water at 60°C for 72 hours.

[0029] In one embodiment of the present invention, the outer layer (1) comprises more than 90% by weight of an aromatic polyether-based polyurethane, and

[0030] There was no visual delamination of the tubes after immersion in water at 60°C for 72 hours.

[0031] In one embodiment of the invention, a method for delivering an aqueous fluid in vivo comprises:

[0032] selecting one or more aqueous compositions effective for treating the condition of the subject, the aqueous composition selected from the group consisting of an aqueous drug suspension, an aqueous composition comprising a chemotherapeutic drug, and an aqueous composition comprising insulin,

[0033] One or more selected aqueous compositions are delivered to the subject through the tube via a flow through the tube.

[0034] In one embodiment of the present invention, a method for preparing a visually clear or transparent and manually flexible medical tube for transporting aqueous fluids in vivo comprises:

[0035] selecting a first polymeric material, the first polymeric material being an aromatic or aliphatic polyether-based polyurethane material having a selected structural stability;

[0036] selecting a second polymeric material, the second polymeric material being a polypropylene material that is inert to aqueous fluids;

[0037] selecting a third polymeric material that is elastomeric in nature and has visual clarity and is selected from one or more of ethylene vinyl acetate copolymer, ethylene acrylate copolymer, ethylene-acrylate maleic anhydride terpolymer, ethylene-acrylate glycidyl methacrylate terpolymer, and maleic anhydride grafted polypropylene;

[0038] coextruding a selected first polymer material, a second polymer material, and a third polymer material to form an outer layer, an inner layer, and an intermediate layer respectively adhering to the medical tube, the outer layer comprising at least 90 weight percent of the first polymer material, the inner layer comprising at least 90 weight percent of the second polymer material, and the intermediate layer comprising at least 90 weight percent of the third polymer material,

[0039] The material is selected to maintain the integrity of the tube to prevent delamination and maintain its visual clarity or transparency when subjected to one or more of ethylene oxide and gamma radiation sterilization,

[0040] The medical tube has a central axial fluid flow channel defined by the radial inner wall surface of the inner layer through which an aqueous fluid is transported, and wherein the tube does not visually delaminate after being immersed in water at 60° C. for 72 hours and then mechanically flattened by manually squeezing the tube from its normally circular cross-sectional state to a flat or oval cross-sectional shape or state.

[0041] In one embodiment of the present invention, a tube (10) suitable for in vivo delivery of an aqueous fluid to a subject comprises an inner layer (3), an intermediate layer (2), and an outer layer (1),

[0042] The tube is prepared by a co-extrusion process, the inner layer (3), the middle layer (2) and the outer layer (1) are all coaxial, the inner layer (3) and the outer layer (1) are bonded to the middle layer (2), and thus bonded to each other.

[0043] wherein the inner layer (3) comprises polypropylene,

[0044] The outer layer (1) comprises a cyclic olefin copolymer, and

[0045] The middle layer (2) is selected from one or more of ethylene vinyl acetate copolymer, ethylene acrylate copolymer, ethylene-acrylate maleic anhydride terpolymer, ethylene-acrylate glycidyl methacrylate terpolymer and maleic anhydride grafted polypropylene.

[0046] In one embodiment of the present invention, the inner layer (3) comprises more than 90 wt% of a polypropylene homopolymer or a polypropylene copolymer, the outer layer (1) comprises more than 90 wt% of a cyclic olefin copolymer, and the middle layer (2) comprises more than 90 wt% of one or more of the following: ethylene vinyl acetate copolymer, ethylene acrylate copolymer, ethylene-acrylate maleic anhydride terpolymer, ethylene-acrylate glycidyl methacrylate terpolymer and maleic anhydride grafted polypropylene.

[0047] In one embodiment of the present invention, the inner layer (3) and the outer layer (1) do not visually delaminate from the middle layer (2) under a stress of up to 20 MPa and a strain of up to 400%, and wherein the tube (10) does not visually delaminate after being immersed in water at 60°C for 72 hours.

[0048] In one embodiment of the invention, a method for delivering an aqueous fluid in vivo comprises:

[0049] selecting one or more aqueous compositions effective for treating the condition of the subject, the aqueous composition selected from the group consisting of an aqueous drug suspension, an aqueous composition comprising a chemotherapeutic drug, an aqueous composition comprising insulin,

[0050] One or more selected aqueous compositions are delivered to the subject through the tube via a flow through the tube.

[0051] In one embodiment of the present invention, a method for preparing a visually clear or transparent and manually flexible medical tube for transporting aqueous fluids in vivo comprises:

[0052] selecting a first polymeric material, the first polymeric material being an aromatic or aliphatic polyether-based polyurethane material having a selected structural stability;

[0053] selecting a second polymeric material, the second polymeric material being a polypropylene material that is inert to aqueous fluids;

[0054] selecting a third polymeric material comprising an acrylate copolymer, being elastomeric in nature and having visual clarity and selected from one or more of ethylene vinyl acetate copolymer, ethylene acrylate copolymer, ethylene-acrylate maleic anhydride terpolymer, ethylene-acrylate glycidyl methacrylate terpolymer, and maleic anhydride grafted polypropylene;

[0055] coextruding a selected first polymer material, a second polymer material, and a third polymer material to form an outer layer, an inner layer, and an intermediate layer respectively adhering to the medical tube, the outer layer comprising at least 90 weight percent of the first polymer material, the inner layer comprising at least 90 weight percent of the second polymer material, and the intermediate layer comprising at least 90 weight percent of the third polymer material,

[0056] The material is selected to maintain the integrity of the tube to prevent delamination and maintain its visual clarity or transparency when subjected to one or more of ethylene oxide and gamma radiation sterilization,

[0057] The medical tube has a central axial fluid flow channel defined by the radial inner wall surface of the inner layer through which an aqueous fluid is transported, and wherein the tube does not visually delaminate after being immersed in water at 60° C. for 72 hours and then mechanically flattened by manually squeezing the tube from its normal circular cross-sectional state to a flat or oval cross-sectional shape or state. BRIEF DESCRIPTION OF THE DRAWINGS

[0058] The accompanying drawings depict one or more embodiments of the present invention, which are illustrated by way of example of the invention, in which:

[0059] Figure 1 is a schematic perspective view of a three-layer tube showing the outer and middle layers cut away to better illustrate the construction and arrangement of the tube;

[0060] Figure 2 is along Figure 1 A cross-sectional view of tube 10 is shown taken along line 2-2.

[0061] Figure 3 is a cross-sectional view of a tube having an inner layer, an intermediate layer, and an outer layer, wherein the tube is subjected to a tensile test using a Lloyd tensile tester. The three-layer tube is subjected to a high tensile force pull or stretch to determine when and if one layer will separate from another layer when a high tensile force is applied, thereby showing the relative degree of adhesion of the intermediate layer to the inner and outer layers.

[0062] Figure 4 is a matrix or chart showing the layer thickness and composition of one embodiment of a 3M3L tube with an EMAC interlayer according to the present invention (SR#2597), an embodiment of a control 2M2L (SR#2604), and two other embodiments of a 3M3L tube with an EVA interlayer according to the present invention (SR#2605 and SR#2606).

[0063] Figure 5is a side view of two sample tubes, 3M3L SR#2597 according to the present invention on the left and control 2M2L on the right, showing the layer separation of each tube after aging for 3 days in distilled water at 60°C and then being tightened and rotated 10 times as measured visually and microscopically (L is in mils (n=5)), wherein the inventive sample on the left has an L value of 4.350 mils, while the control tube on the right has a larger L value of 51.656 mils (the layer separation of the 2M2L tube is significantly larger).

[0064] Figure 6 It is shown as Figure 4 A matrix or chart of side view microscope measurements (L in mils) of mid-tubes listing five samples of SR#2597 (invention, 3M3L with EMAC midlayer), SR#2604 (2M2L control), SR#2605 and SR#2606 (invention, 3M3L with EVA midlayer), along with the average of L for each group of five samples, and showing that the 3M3L sample has a much lower layer separation L value than the 2M2L sample.

[0065] Figure 7 is a 200X microscopic cross-sectional view of two sample tubes, 3M3L SR#2597 according to the present invention on the left and control 2M2L SR#2604 on the right, showing visual layer separation and visual assessment grades (1-5 scale) after aging each tube in distilled water at 60°C for 3 days and then tightening and rotating 10 times, wherein the grade of the inventive sample on the left is 2.5 and the control tube on the right has a larger grade of 4.75 (lower values ​​are expected).

[0066] Figure 8 It is shown Figure 6 , which lists 5 samples of SR#2597 (the present invention, 3M3L with an EMAC middle layer), SR#2604 (2M2L control), SR#2605 and SR#2606 (the present invention, 3M3L with an EVA middle layer), and the average of the evaluation grades for each group of 5 samples, and shows that the 3M3L sample has a much lower layer separation L value than the 2M2L sample.

[0067] Fig. 9 is a graph showing tensile curves for a 2M2L tube (SR#2604) and various 3M3L tubes, each having a different intermediate layer (EMACSR#2597, EVA SR#2605, and EVA SR#2606), wherein the tubes are configured for delivering insulin, with stress (psi) on the vertical axis and strain (%) on the horizontal axis, wherein the 3M3L tubes all show much lower layer separation (also known as sleeves) than the 2M2L samples.

[0068] Fig.10 It is shown Figure 8 A matrix or chart of the different tensile properties of various tubes in Figure 8 Various tubes, namely 2M2L (SR#2604) and 3M3L tubes, wherein the 3M3L tubes have different middle layers (EMAC SR#2597, EVASR#2605 and EVASR#2606), wherein the 3M3L tubes all show much better tensile properties and lower layer separation (also known as sleeve) than the 2M2L samples. DETAILED DESCRIPTION

[0069] Figure 1 An embodiment of a coextruded three-layer tube 10 according to the present invention is shown, comprising an outer layer 1 composed of at least about 90% by weight of a polyurethane material, typically a polytetramethylene glycol-based polyurethane material, wherein an example of a polyurethane is Lubrizol TPU Pellethane 2363-90AE. Alternatively, the outer layer may comprise a cyclic olefin copolymer material, such as Topas E-140.

[0070] like Figure 1 As shown, the tube includes an inner fluid contact layer 3 and an intermediate adhesive layer 2, the inner fluid contact layer 3 is generally composed of at least about 90% by weight of a polypropylene material (e.g., Ineos ROIC), and the intermediate adhesive layer 2 is composed of at least about 90% by weight of an ethylene ethyl acrylate copolymer, an ethylene methyl acrylate copolymer, an anhydride-grafted ethylene methyl acrylate copolymer, a copolymer of two or more of the acrylates, or a mixture of two or more of the acrylate-based compounds or compositions. An example of a suitable ethylene ethyl acrylate copolymer is Dow Amplify EA103 (ethylene ethyl acrylate is about 19.5% by weight). An example of a suitable ethylene methyl acrylate copolymer is Westlake MASP2268 (ethylene methyl acrylate is about 24% by weight), Westlake MASP2220 (ethylene methyl acrylate is about 20% by weight). An example of a suitable anhydride-grafted ethylene methyl acrylate copolymer is Westlake Tymax GA7001 (anhydride-grafted ethylene methyl acrylate). Alternatively, the intermediate layer may contain an ethylene-vinyl acetate copolymer.

[0071] like Figure 1As shown, outer layer 1 has a radially inwardly facing surface S1 that is bonded and adhered to radially outwardly facing surface S2 of intermediate layer 2. Similarly, inner layer 3 has a radially outwardly facing surface S4 that is bonded and adhered to radially inwardly facing surface S3 of intermediate layer 2. Intermediate layer 2 is adhered to outer layer 1 and inner layer 3 such that when tube 10 is subjected to stresses up to about 20 MPa and strains up to about 400% (measured by stretching tube 10 having an axial length L of about 2 inches along its axis A at a stretching rate of about 12 inches / minute under ambient conditions of about 72 degrees Fahrenheit and about 50% relative humidity using a Lloyd LR5KPlus mechanical tester), layers 1 and 3 remain adhered to layer 2 and to each other, with the breaking points of tube 10 being about 17-22 MPa and about 300% to 450%. The layers 1, 2, 3 of such a tube 10 do not visually delaminate after being immersed in water at 60°C for 36 or 72 hours and then mechanically flattened by manually squeezing the tube from its normal circular cross-sectional state to a flat or oval cross-sectional shape or state.

[0072] like Figure 1 and Figure 2 As shown, layers 1, 2, 3 form a structurally stable wall that surrounds and encloses a central hollow fluid channel 20, wherein an aqueous solution is transported through the channel 20 and flows in the axial direction A, and which contacts the radially inwardly facing surface S5 of the inner layer 3. The intermediate layer 2 binds and holds the inner layer 3 and the outer layer 1 together.

[0073] The inner layer 3 provides a radially inner fluid contact surface S5, and the cross-sectional thickness T1 of the inner layer 3 is generally about 0.001 inches to about 0.025 inches. The cross-sectional thickness T2 of the intermediate layer 2 is generally about 0.001 inches to about 0.025 inches. The cross-sectional thickness T3 of the outer layer 1 is generally about 0.001 inches to about 0.025 inches.

[0074] The polypropylene material is preferably a homopolymer or copolymer of propylene and ethylene or a mixture thereof. A typical polypropylene material is Ineos R01C.

[0075] Polyurethane elastomer (TPU) is generally a reaction product of a polyol and an isocyanate and generally includes a combination of a hard segment domain and a soft segment domain. Aromatic polyether-based TPU or aliphatic polyether-based TPU can be used, for example, polytetramethylene glycol-based polyurethane is used. Preferably, TPU includes Lubrizol's Pellethane 2363-80AE series (e.g., Lubrizol TPU Pellethane 2363-90AE) and BASF 1190A.

[0076] The respective thickness of each layer of the tube 10 can be controlled by the extrusion tool used, such as the "Tri Die" extrusion equipment manufactured by the Genca Division of General Cable Company of Clearwater, Fla. The extrusion equipment is selected so that uniform thickness of the layers 1, 2, 3 can be provided along substantially the entire axial length L of all three layers 1, 2, 3.

[0077] The polymeric material comprising layers 1, 2, 3 is selected so as to be visually clear or transparent and manually flexible along and about the tube axis A. The polymeric material is selected so as to maintain the integrity of the tube 10 (i.e., no delamination) and its transparency or clarity after the tube 10 has been subjected to ethylene oxide (EtO) and gamma radiation sterilization processes.

[0078] Figure 3 is a cross-sectional view of a tube having an inner layer of polypropylene, an intermediate layer of EMAC, and an outer layer having one of TPU or COC. The outer layer of the tube on the left in the figure is a polyurethane material, the intermediate layer is EMAC, and the inner layer is a polypropylene material. From the cross-section of the tube subjected to the high tensile force of the Lloyd apparatus, it can be seen that the three layers remain substantially adhered to each other. Further, as Figure 3 As shown, the tube on the right has the same polypropylene inner layer material and the same EMAC middle layer material, but it has an outer layer composed of a cyclic olefin copolymer (COC) material. As shown, similar to the tube on the left, the three layers of the tube are substantially kept adhered to each other.

[0079] Further testing of various embodiments of the present invention will be described below and will be presented in Figure 4-10 The various materials and layer structures of the samples of the three-layer (3M3L) pipe of three materials according to the present invention are shown below, and the control sample is a two-layer (2M2L) pipe of two materials:

[0080] Material:

[0081] PP Flint Hills 23R2

[0082] ·EMAC EMAC SP2268

[0083] ·EVA Celanese 2604A

[0084] EVA Celanese 2803A

[0085] ·TPU Texin RXT90A

[0086] sample:

[0087] SR2604(2M2L) control

[0088] PP Flint Hills 23R2

[0089] TPU Texin RXT90A

[0090] SR2597(3M3L)

[0091] PP Flint Hills 23R2

[0092] EMAC SP2268

[0093] TPU Texin RXT90A

[0094] SR2605(3M3L)

[0095] PP Flint Hills 23R2

[0096] EVACelanese 2604A

[0097] TPU Texin RXT90A

[0098] SR2606(3M3L)

[0099] PP Flint Hills 23R2

[0100] EVA Celanese 2803A

[0101] TPU Texin RXT90A

[0102] Figure 4 is a matrix or chart showing the layer thickness and composition of one embodiment of a 3M3L tube with an EMAC interlayer according to the present invention (SR#2597), an embodiment of a control 2M2L (SR#2604), and two other embodiments of a 3M3L tube with an EVA interlayer according to the present invention (SR#2605 and SR#2606).

[0103] Figure 5 is a side view of two sample tubes, 3M3L SR#2597 according to the present invention on the left and 2M2L, a control example, on the right, showing the layer separation of each tube after aging for 3 days in distilled water at 60°C and then being tightened and rotated 10 times as measured visually and microscopically (L is in mils (n=5)), wherein the sample of the present invention on the left has an L value of 4.350 mils, while the control tube on the right has a larger L value of 51.656 mils (the layer separation of the 2M2L tube is significantly larger).

[0104] Figure 6 It is shown as Figure 4 , which lists 5 samples of SR#2597 (the present invention, 3M3L with EMAC middle layer), SR#2604 (2M2L control), SR#2605 and SR#2606 (the present invention, 3M3L with EVA middle layer), and the average value of L for each group of 5 samples, and shows that the 3M3L sample has a much lower layer separation L value than the 2M2L sample.

[0105] Figure 7 is a 200X microscopic cross-sectional view of two sample tubes, 3M3L SR#2597 according to the present invention on the left and control 2M2L SR#2604 on the right, showing visual layer separation and visual assessment grades (1-5 scale) after aging each tube in distilled water at 60°C for 3 days and then tightening and rotating 10 times, wherein the grade of the inventive sample on the left is 2.5 and the control tube on the right has a larger grade of 4.75 (lower values ​​are expected).

[0106] Figure 8 It is shown Figure 6 , which lists 5 samples of SR#2597 (the present invention, 3M3L with an EMAC middle layer), SR#2604 (2M2L control), SR#2605 and SR#2606 (the present invention, 3M3L with an EVA middle layer), and the average of the evaluation grades for each group of 5 samples, and shows that the 3M3L sample has a much lower layer separation L value than the 2M2L sample.

[0107] Fig. 9 is a graph showing tensile curves of a 2M2L tube (SR#2604) and various 3M3L tubes (each having a different intermediate layer (EMACSR#2597, EVA SR#2605, and EVA SR#2606)), wherein the tubes are configured for delivering insulin, with stress (psi) on the vertical axis and strain (%) on the horizontal axis, wherein the 3M3L tubes all show much lower layer separation (also known as sleeves) than the 2M2L samples.

[0108] Fig.10 It is shown Figure 8 A matrix or chart of the different tensile properties of various tubes in Figure 8 Various tubes in the test piece, namely 2M2L (SR#2604) and 3M3L tubes, wherein the 3M3L tubes have different middle layers (EMAC SR#2597, EVA SR#2605 and EVASR#2606), wherein the 3M3L tubes all show much better tensile properties and lower layer separation (also known as casing) than the 2M2L samples.

[0109] In various embodiments, the intermediate layer generally acts as a barrier to prevent migration of mobile moieties, including monomers, short chain polymers, ions, water, small organic molecules, metals, plasticizers, and catalysts, between or from the layers and the central flow channel.

[0110] In various embodiments, the polymer material layers are coextruded together to prepare the tube so that the outer and inner layers adhere to the middle layer and thus to each other. The tube is formed with a central hollow passage, hole or channel radially surrounded and defined by the polymer layer serving as the tube wall.

[0111] refer to Figure 1 , Figure 2 Preferably, the thickness T3 of the outer layer 1 is about 0.001" to about 0.025", the thickness T1 of the inner layer 3 is about 0.001" to about 0.025", and the thickness T2 of the middle layer 2 is about 0.001" to about 0.025". Layers 1, 2, and 3 together form a tubular wall that surrounds and defines the central fluid flow channel 20.

[0112] The polymeric materials are preferably "non-contaminating," meaning that they do not contain more than negligible amounts of potentially undesirable materials (typically less than about 0.5 weight percent, preferably less than about 0.2 weight percent) and / or prevent leaching or leakage of undesirable materials (such as plasticizers, catalysts, monomers, metals, salts, ions, or other substances that may be undesirable to humans) into an aqueous solution or medium with which one or another of the three layers of the tube may come into contact during the normal process of using the tube to deliver aqueous fluids (e.g., insulin, chemotherapeutic drugs, and other potentially unstable aqueous drug suspensions) to or from a human subject. In addition to acting as an adhesive between and adhering to the outer and inner layers, the middle layer can also prevent the outer and inner layers from delaminating from the middle layer under conditions of relatively low moderate stress or strain. In addition, the middle layer can act as a barrier to leaching or leakage of contaminants from the outer layer into or through the inner layer into the hollow central hole or channel of the tube.

[0113] The polypropylene material generally comprises one or more of a polypropylene homopolymer and a polypropylene copolymer.

[0114] Ethylene vinyl acetate (EVA), ethylene ethyl acrylate copolymer (EEA), ethylene methyl acrylate (EMA) copolymer and anhydride grafted ethylene methyl acrylate (AEMA) copolymer, which are elastomeric in nature and have excellent visual clarity. In the usual 3M3L coextrusion process, TPU, EVA, EEA or EMA or AEMA and PP are melt extruded through a die to form a tubular extrudate, which is then cooled by a conventional water bath or water vacuum tank and subsequently wound or cut into specific lengths for use. The elasticity and softness level of EVA, EEA, EMA, AEMA or their copolymers is controlled by the content of vinyl acetate, ethyl acrylate or methyl acrylate comonomers used with ethylene during the copolymerization process. The three-layer tubes made by this coextrusion process act in an integral manner, and after being strained or stretched in a tensile manner along the longitudinal axis of the tube at a stress of up to about 20 MPa and a strain of about 400%, they will return to nearly their original shape and size, and there is no visible delamination between any layers after being immersed in water at about 60°C for about 36 hours.

[0115] Cyclic olefin copolymers are usually prepared by:

[0116] Cyclic monomers copolymerized with ethylene chains, or

[0117] By ring-opening metathesis polymerization of cyclic monomers followed by hydrogenation.

[0118] Cyclic olefin copolymers can be prepared by:

[0119] Chain copolymerization of cyclic monomers consisting of one or more of norbornene (8,9,10-trinorborn-2-ene) and 1,2,3,4,4a,5,8,8a-octahydro-1,4:5,8-dimethanonaphthalene with ethylene, or

[0120] By ring-opening metathesis polymerization of cyclic monomers followed by hydrogenation.

[0121] The foregoing description is intended to illustrate rather than limit the scope of the present invention, and those skilled in the art will appreciate that the above description contemplates equivalents thereof and that changes and modifications may be made thereto without departing from the present invention, and all such equivalents, changes and modifications fall within the scope of the present claims.

Claims

1. A tube (10) suitable for delivering an aqueous fluid in vivo to a subject, comprising an inner layer (3), an intermediate layer (2) and an outer layer (1), in, The tube is prepared by a co-extrusion process, the inner layer (3), the middle layer (2) and the outer layer (1) are all coaxial, and the inner layer (3) and the outer layer (1) are bonded to the middle layer (2) and thus bonded to each other. wherein the inner layer (3) comprises polypropylene, The outer layer (1) comprises thermoplastic polyurethane, and The intermediate layer (2) is selected from one or more of ethylene vinyl acetate copolymer, ethylene acrylate copolymer, ethylene-acrylate maleic anhydride terpolymer, ethylene-acrylate glycidyl methacrylate terpolymer and maleic anhydride grafted polypropylene.

2. The tube according to claim 1, wherein the intermediate layer (2) comprises ethylene ethyl acrylate copolymer or ethylene methyl acrylate copolymer or anhydride grafted ethylene methyl acrylate copolymer, copolymers of two or more of said acrylates or mixtures of two or more of the above.

3. The tube according to claim 1, wherein the intermediate layer (2) comprises ethylene vinyl acetate.

4. The tube (10) according to claim 1, wherein the inner layer (3) comprises greater than 90 wt% of a polypropylene homopolymer or a polypropylene copolymer, the outer layer (1) comprises greater than 90 wt% of an aromatic or aliphatic polyether-based polyurethane, and the intermediate layer (2) comprises greater than 90 wt% of one or more of the following: ethylene vinyl acetate copolymer, ethylene acrylate copolymer, ethylene-acrylate maleic anhydride terpolymer, ethylene-acrylate glycidyl methacrylate terpolymer and maleic anhydride grafted polypropylene.

5. The tube according to claim 4, wherein the intermediate layer (2) comprises ethylene ethyl acrylate copolymer having an ethyl acrylate content of at least 19.5% by weight.

6. The tube according to claim 4, wherein the intermediate layer (2) comprises more than 90% by weight of ethylene methyl acrylate copolymer.

7. The tube according to claim 4, wherein the intermediate layer (2) comprises ethylene vinyl acetate having a vinyl acetate content of at least 19.5% by weight.

8. The tube according to claim 1, wherein the inner layer (3) comprises more than 90 wt% of a polypropylene homopolymer or a polypropylene copolymer or a mixture of said homopolymer and said copolymer, and the outer layer (1) comprises more than 90 wt% of a polytetramethylene glycol-based polyurethane.

9. The tube of claim 1 wherein the outer layer of polyurethane has a thickness of 0.0254 mm to 0.635 mm (0.001 inch to 0.025 inch), the inner polypropylene layer has a thickness of 0.0254 mm to 0.635 mm (0.001 inch to 0.025 inch), and the middle layer has a thickness of 0.0254 mm to 0.635 mm (0.001 inch to 0.025 inch).

10. The tube according to claim 1, wherein the inner layer (3) and the outer layer (1) do not visually delaminate from the middle layer (2) under a stress of at most 20 MPa and a strain of at most 400%.

11. The tube of claim 1, wherein the tube (10) is visually free of delamination when immersed in water at 60°C for 72 hours.

12. A tube according to claim 1, wherein the tube (10) has a central axial fluid flow channel through which an aqueous fluid flows, the inner layer (3) has a radial inner wall surface in contact with the aqueous fluid, and under a stress of up to 20 MPa and a strain of up to 400%, the outer layer (1) and the inner layer (3) will not delaminate from the middle layer (2), and wherein the tube (10) is visually free of delamination after being immersed in water at 60°C for 72 hours.

13. The tube according to claim 1, wherein the inner layer (3) and the outer layer (1) do not visually delaminate from the middle layer (2) under a stress of up to 20 MPa and a strain of up to 400%, and wherein the tube (10) does not visually delaminate after being immersed in water at 60°C for 72 hours.

14. The tube according to claim 1, wherein the outer layer (1) comprises more than 90 wt% of an aromatic polyether-based polyurethane, and wherein the tube is visually free of delamination after immersion in water at 60°C for 72 hours.

15. A method for delivering an aqueous fluid in vivo, comprising: selecting one or more aqueous compositions effective for treating the condition of the subject, the aqueous composition selected from the group consisting of an aqueous drug suspension, an aqueous composition comprising a chemotherapeutic drug, and an aqueous composition comprising insulin, One or more selected aqueous compositions are delivered to a subject through the tube according to claim 1 via a flow through the tube.

16. A method for preparing a visually clear or transparent and manually flexible medical tube for conveying aqueous fluids in vivo, the method comprising: selecting a first polymeric material, the first polymeric material being an aromatic or aliphatic polyether-based polyurethane material having a selected structural stability; and selecting a second polymeric material, the second polymeric material being a polypropylene material that is inert to aqueous fluids; selecting a third polymeric material that is elastomeric in nature and has visual clarity and is selected from one or more of ethylene vinyl acetate copolymer, ethylene acrylate copolymer, ethylene-acrylate maleic anhydride terpolymer, ethylene-acrylate glycidyl methacrylate terpolymer, and maleic anhydride grafted polypropylene; coextruding a selected first polymer material, a second polymer material, and a third polymer material to form an outer layer, an inner layer, and an intermediate layer respectively adhering to the medical tube, the outer layer comprising at least 90 weight percent of the first polymer material, the inner layer comprising at least 90 weight percent of the second polymer material, and the intermediate layer comprising at least 90 weight percent of the third polymer material, The material is selected to maintain the integrity of the tube to prevent delamination and maintain its visual clarity or transparency when subjected to one or more of ethylene oxide and gamma radiation sterilization, The medical tube has a central axial fluid flow channel defined by the radial inner wall surface of the inner layer through which an aqueous fluid is transported, and wherein the tube does not visually delaminate after being immersed in water at 60° C. for 72 hours and then mechanically flattened by manually squeezing the tube from its normal circular cross-sectional state to a flat or oval cross-sectional shape or state.

17. A tube (10) suitable for delivering an aqueous fluid in vivo to a subject, comprising an inner layer (3), an intermediate layer (2) and an outer layer (1), in, The tube is formed by a co-extrusion process, the inner layer (3), the middle layer (2) and the outer layer (1) are all coaxial, the inner layer (3) and the outer layer (1) are bonded to the middle layer (2) and thus bonded to each other, wherein the inner layer (3) comprises polypropylene, The outer layer (1) comprises a cyclic olefin copolymer, and The intermediate layer (2) is selected from one or more of ethylene vinyl acetate copolymer, ethylene acrylate copolymer, ethylene-acrylate maleic anhydride terpolymer, ethylene-acrylate glycidyl methacrylate terpolymer and maleic anhydride grafted polypropylene.

18. The tube (10) according to claim 17, wherein the inner layer (3) comprises greater than 90 wt% of a polypropylene homopolymer or a polypropylene copolymer, the outer layer (1) comprises greater than 90 wt% of a cyclic olefin copolymer, and the intermediate layer (2) comprises greater than 90 wt% of one or more of an ethylene vinyl acetate copolymer, an ethylene acrylate copolymer, an ethylene-acrylate maleic anhydride terpolymer, an ethylene-acrylate glycidyl methacrylate terpolymer, and a maleic anhydride grafted polypropylene.

19. The tube according to claim 17, wherein the inner layer (3) and the outer layer (1) do not visually delaminate from the middle layer (2) under a stress of up to 20 MPa and a strain of up to 400%, and wherein the tube (10) does not visually delaminate after being immersed in water at 60°C for 72 hours.

20. A method for delivering an aqueous fluid in vivo, comprising: selecting one or more aqueous compositions effective for treating the condition of the subject, the aqueous composition selected from the group consisting of an aqueous drug suspension, an aqueous composition comprising a chemotherapeutic drug, an aqueous composition comprising insulin, One or more selected aqueous compositions are delivered to a subject through the tube according to claim 17 via a flow through the tube.

21. A method for preparing a visually clear or transparent and manually flexible medical tube for conveying aqueous fluids in vivo, the method comprising: selecting a first polymeric material, the first polymeric material being an aromatic or aliphatic polyether-based polyurethane material having a selected structural stability; selecting a second polymeric material, the second polymeric material being a polypropylene material that is inert to aqueous fluids; selecting a third polymeric material comprising an acrylate copolymer, being elastomeric in nature and having visual clarity and selected from one or more of ethylene vinyl acetate copolymer, ethylene acrylate copolymer, ethylene-acrylate maleic anhydride terpolymer, ethylene-acrylate glycidyl methacrylate terpolymer, and maleic anhydride grafted polypropylene; coextruding a selected first polymer material, a second polymer material, and a third polymer material to form an outer layer, an inner layer, and an intermediate layer respectively adhered to the medical tube, the outer layer comprising at least 90% by weight of the first polymer material, the inner layer comprising at least 90% by weight of the second polymer material, and the intermediate layer comprising at least 90% by weight of the third polymer material, The material is selected to maintain the integrity of the tube to prevent delamination and maintain its visual clarity or transparency when subjected to one or more of ethylene oxide and gamma radiation sterilization, The medical tube has a central axial fluid flow channel defined by the radial inner wall surface of the inner layer through which an aqueous fluid is transported, and wherein the tube does not visually delaminate after being immersed in water at 60° C. for 72 hours and then mechanically flattened by manually squeezing the tube from its normal circular cross-sectional state to a flat or oval cross-sectional shape or state.